TORONTO , May 28, 2020 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three and six months ended March 31, 2020 . SQI is a Toronto -based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. SQI received New York State Department of Health ("NYSDOH") approval of rheumatoid arthritis direct-to-consumer ("DTC") test.